375 related articles for article (PubMed ID: 22312908)
1. [The glucose, glycotoxins and glycation products: the involvement into pathogenesis of microangiopathies, arteriolosclerosis and atherosclerosis].
Titov VN; Shiriaeva IuK
Klin Lab Diagn; 2011 Nov; (11):3-13. PubMed ID: 22312908
[TBL] [Abstract][Full Text] [Related]
2. [Arteriolosclerosis and atherosclerosis. Pathology of the distal and proximal arterial bed. Pathogenesis of diabetic microangiopathy].
Titov VN; Shiriaeva IuK
Klin Lab Diagn; 2011 Apr; (4):3-14. PubMed ID: 21739639
[TBL] [Abstract][Full Text] [Related]
3. [The pericytes, endothelium monolayer, collagen and elastin chains as the elements of areolar tissue and the substrates of chemical reaction of glyserization].
Titov VN; Shiriaeva IuK
Klin Lab Diagn; 2011 Jul; (7):3-14. PubMed ID: 21901889
[TBL] [Abstract][Full Text] [Related]
4. [Glucose, glycotoxins, and protein glycation products: the role in pathogensis].
Titov VN; Khokhlova NV; Shiriaeva IuK
Klin Med (Mosk); 2013; 91(3):15-24. PubMed ID: 23789446
[TBL] [Abstract][Full Text] [Related]
5. [The unity of image recognition of tolite homothetic receptors and glycosylation end product receptors in biologic function in case of diabetes].
Titov VN; Shiriaeva IuK
Klin Lab Diagn; 2011 Aug; (8):3-15. PubMed ID: 22164410
[TBL] [Abstract][Full Text] [Related]
6. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose.
Thornalley PJ; Langborg A; Minhas HS
Biochem J; 1999 Nov; 344 Pt 1(Pt 1):109-16. PubMed ID: 10548540
[TBL] [Abstract][Full Text] [Related]
7. Chemistry and pathobiology of advanced glycation end products.
Schleicher ED; Bierhaus A; Häring HU; Nawroth PP; Lehmann R
Contrib Nephrol; 2001; (131):1-9. PubMed ID: 11125554
[No Abstract] [Full Text] [Related]
8. The Role of Glyoxalase in Glycation and Carbonyl Stress Induced Metabolic Disorders.
Saeed M; Kausar MA; Singh R; Siddiqui AJ; Akhter A
Curr Protein Pept Sci; 2020; 21(9):846-859. PubMed ID: 32368974
[TBL] [Abstract][Full Text] [Related]
9. Investigating the Glycating Effects of Glucose, Glyoxal and Methylglyoxal on Human Sperm.
Nevin C; McNeil L; Ahmed N; Murgatroyd C; Brison D; Carroll M
Sci Rep; 2018 Jun; 8(1):9002. PubMed ID: 29899461
[TBL] [Abstract][Full Text] [Related]
10. Advanced glycation: a novel outlook on atherosclerosis.
Price CL; Knight SC
Curr Pharm Des; 2007; 13(36):3681-7. PubMed ID: 18220806
[TBL] [Abstract][Full Text] [Related]
11. Cocoa melanoidins reduce the formation of dietary advanced glycation end-products in dairy mimicking system.
Zhang H; Troise AD; Zhang H; Fogliano V
Food Chem; 2021 May; 345():128827. PubMed ID: 33348132
[TBL] [Abstract][Full Text] [Related]
12. Reaction of metformin with dicarbonyl compounds. Possible implication in the inhibition of advanced glycation end product formation.
Ruggiero-Lopez D; Lecomte M; Moinet G; Patereau G; Lagarde M; Wiernsperger N
Biochem Pharmacol; 1999 Dec; 58(11):1765-73. PubMed ID: 10571251
[TBL] [Abstract][Full Text] [Related]
13. Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor.
Nagai R; Matsumoto K; Ling X; Suzuki H; Araki T; Horiuchi S
Diabetes; 2000 Oct; 49(10):1714-23. PubMed ID: 11016456
[TBL] [Abstract][Full Text] [Related]
14. [Non-enzymatic glycation of proteins: from diabetes to cancer].
Ansari NA; Rasheed Z
Biomed Khim; 2010; 56(2):168-78. PubMed ID: 21341505
[TBL] [Abstract][Full Text] [Related]
15. Interactions between the sorbitol pathway, non-enzymatic glycation, and diabetic vascular dysfunction.
Ido Y; Kilo C; Williamson JR
Nephrol Dial Transplant; 1996; 11 Suppl 5():72-5. PubMed ID: 9044312
[TBL] [Abstract][Full Text] [Related]
16. Modification of chickpea cystatin by reactive dicarbonyl species: Glycation, oxidation and aggregation.
Bhat SA; Bhat WF; Afsar M; Khan MS; Al-Bagmi MS; Bano B
Arch Biochem Biophys; 2018 Jul; 650():103-115. PubMed ID: 29775569
[TBL] [Abstract][Full Text] [Related]
17. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.
Schmidt AM; Yan SD; Wautier JL; Stern D
Circ Res; 1999 Mar; 84(5):489-97. PubMed ID: 10082470
[TBL] [Abstract][Full Text] [Related]
18. [Glycation of extracellular matrix proteins and its role in atherosclerosis].
Kuzan A; Chwiłkowska A; Kobielarz M; Pezowicz C; Gamian A
Postepy Hig Med Dosw (Online); 2012 Oct; 66():804-9. PubMed ID: 23175335
[TBL] [Abstract][Full Text] [Related]
19. Protein glycation: creation of catalytic sites for free radical generation.
Yim MB; Yim HS; Lee C; Kang SO; Chock PB
Ann N Y Acad Sci; 2001 Apr; 928():48-53. PubMed ID: 11795527
[TBL] [Abstract][Full Text] [Related]
20. Immunological evidence that non-carboxymethyllysine advanced glycation end-products are produced from short chain sugars and dicarbonyl compounds in vivo.
Takeuchi M; Makita Z; Bucala R; Suzuki T; Koike T; Kameda Y
Mol Med; 2000 Feb; 6(2):114-25. PubMed ID: 10859028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
